Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000064

President, Research & Develop. sold 18,219 shares at an average $18.62 ($339,281)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan President, Research & Develop. 2024-11-04 Sale 10b5-1 −749 $18.02 $13,498 182,467 D
Sethuraman Natarajan President, Research & Develop. 2024-11-05 Sale 10b5-1 −5,171 $18.18 $94,006 177,296 D
Sethuraman Natarajan President, Research & Develop. 2024-11-06 Sale 10b5-1 −9,554 $18.71 $178,752 167,742 D
Sethuraman Natarajan President, Research & Develop. 2024-11-06 Sale 10b5-1 −2,745 $19.32 $53,024 164,997 D
Open-market sales · 18,219 sh · avg $18.62 · $339,281
Loading xslF345X05/wk-form4_1730929001.xml…